Torres Denice

Glaukos Corporation · Director

Torres Denice is listed in filings as Director at Glaukos Corporation. This profile follows SEC Form 4 activity through Jun 1, 2026, including 12 public disclosures. Recent filings connect the profile to Glaukos Corporation (GKOS), Celldex Therapeutics, Inc. (CLDX), and 2seventy bio, Inc. (TSVT). The current snapshot covers public activity from Jun 12, 2024 to Jun 1, 2026. Reported amounts are shown as $160.0K to $298.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.